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Objective: To study the effects of adding dexmedetomidine to bupivacaine in transverses abdominis plane block 
in comparison with using bupivacaine alone.  
Materials and Methods: This was a prospective comparative study that was conducted in the Anaesthesia 
Department, CMH, Lahore over a period of six months from 1st June 2020 to 30th November 2020. Fifty patients of 
the American Society of Anesthesiologist Class I and II with an age range between 40 to 60 years were divided 
into two groups. Group B received 20ml of 0.25% bupivacaine with 2ml of normal saline on each side in the 
transversus abdominis plane block while group BD was given 20ml of 0.25% bupivacaine with dexmedetomidine 
0.5mcg/kg on each side (in a volume of 2ml). Post-operative pain was assessed with a visual analogue scale. 
Rescue analgesia was given when a score of greater than 3 was observed using this scale. Time to first rescue 
analgesia was noted. Total opioid consumption in the first 24 hours was also recorded. Patients were observed for 
postoperative hypotension and bradycardia. 
Results: The mean-time for the first dose of analgesia for group B and BD was 302.92 ± 24.01 and 419.28 ± 31.97 
minutes respectively with a p-value of 0.001. The mean of the total consumption of opioids in 24 hours post-
operatively for group B and BD was 14.20±2.36 and 10.40±1.38 mg respectively with a p-value of 0.001. 
Hypotension was not seen in any patient in either group. Only one patient developed bradycardia and he 
belonged to group BD. P-value was 0.327. 
Conclusion: The addition of dexmedetomidine to bupivacaine for transversus abdominis plane block for 
postoperative analgesia significantly prolongs the duration of analgesia and reduces the postoperative opioid 
requirements. 










Enhanced recovery after surgery (ERAS) protocol aims 
to reduce the length of hospital stay, reduction in 
postoperative complications, and early recovery to 
normal life for the patient.1 Adequate control of 
postoperative pain is a major element for early 
recovery.2 Abdominal hysterectomy is a major non-
obstetric gynecological surgery in women where pain 
has traditionally been controlled by opioids mainly. 
However, reducing the consumption of perioperative 
opioids is a cornerstone for early recovery after 
surgery.3 
Transversus abdominis plane (TAP) block involves the 
spread of local anesthetic in the neurovascular plane 
between the internal oblique and transversus 
abdominis muscle thus blocking abdominal wall 
afferent nerve fibres.4 It has proved to significantly 
reduce pain after abdominal surgeries.5 However one 
major limitation of TAP block is that it only covers the 
somatic component of pain and provides no efficacy 
for a visceral component.6 
Various adjuvants have been tried with bupivacaine 
for TAP block to prolong the duration, provide quality 
analgesia and reduce postoperative opioid 
requirements. These include clonidine, magnesium 
sulphate7, ketorolac, and dexmedetomidine.8 
Dexmedetomidine9 is an alpha 2 adrenoceptor agonist. 
The exact mechanism by which alpha 2 agonists 
produce analgesia is not fully understood. However, it 
acts both at peripheral receptors and receptors in the 
brain thus inhibiting the propagation of pain signals 
and providing sedation respectively. It also has a 
vagomimetic action, by virtue of which it can cause 
bradycardia and hypotension when given in 
intravenous boluses. Fortunately, this effect is either 
very minimal or absent when it is used intrathecally or 
for peripheral nerve blocks. 
Ultrasound-guided TAP block is recently been used in 
Pakistan for postoperative pain control after 
abdominal hysterectomy. We aim to see the effects of 
adding dexmedetomidine to bupivacaine for 
postoperative pain control and opioids consumption 
after abdominal hysterectomy. 
 
Materials and Methods 
 
This was a prospective comparative study that was 
conducted in the Anaesthesia Department, CMH, 
Lahore over a period of six months from 1st June 2020 
to 30th November 2020. Approval from the 
institutional ethical review committee was taken 
before commencement of the study (ERC Reference 
letter number. 577/2020/Trg/Adm). Patients with an 
age range between 40 to 60 years with the American 
Society of Anesthesiologists (ASA) class of I and II 
undergoing abdominal hysterectomy were included in 
this study. Patients having coagulopathy, liver disease, 
morbid obesity, infection at the site of injection, 
previous abdominoplasty, allergy to local anesthetics, 
or those with chronic use of analgesics and those 
unwilling to participate in the study were excluded 
from the study.  
A total of fifty patients were included in the study. 
G*Power 3 software version 3.1.9.710 was used to 
calculate the sample size with a power of 80% to detect 
an effect size of 0.8 in the outcome measures of 
interest, assuming a type I error of 0.058. They were 
randomly divided into two equal groups.  Group B 
received bupivacaine only in TAP block and group BD 
received bupivacaine with dexmedetomidine. Visual 
analogue scale (VAS) was explained to all patients on 
the day of pre-operative assessment where 0 signified 
‘no pain’ while 10 signified ‘worst pain’. 
Written consent was taken from all the patients who 
were willing to participate in the study. Patients were 
monitored with standard monitoring protocols of the 
hospital which included pulse-oximetry, 
electrocardiography (ECG), non-invasive blood 
pressure (NIBP), capnography, and temperature. All 
patients were premedicated with midazolam 
0.03mg/kg, ondansetron 0.1 mg/kg and 
dexamethasone 4 mg intravenously (IV). General 
anesthesia was induced with propofol 1-2mg/kg and 
atracurium 0.5 mg/kg.  An endotracheal tube was 
placed and tracheal intubation was confirmed by 
bilateral chest auscultation and capnography. 
Anesthesia was maintained with isoflurane 1-2 
minimum alveolar concentration (MAC) and oxygen. 
Nalbuphine 0.01 mg/kg and acetaminophen 15 mg/kg 
was given intravenously for analgesia. After the 
surgery, a TAP block was performed in both groups 
under ultrasound guidance by one of the researchers.  
Group B received 20 ml of 0.25% bupivacaine with 2 
ml of normal saline on each side while group BD was 
given 20 ml of 0.25% bupivacaine with 
dexmedetomidine 0.5mcg/kg (in a volume of 2 ml) on 
each side. In all patients, residual neuromuscular 
blockade was reversed with neostigmine and 
glycopyrrolate. All patients were extubated fully 
awake after adequate reversal of neuromuscular 
blockade. 
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VAS was used to assess the severity of pain. Injection 
nalbuphine 5 mg was given intravenously as rescue 
analgesia when VAS ≥ 4. Time to first rescue analgesia 
was noted. Total opioid consumption for the first 24 
hours was also recorded. Patients were observed for 
postoperative hypotension and bradycardia. 
Hypotension was labeled when the MAP of the patient 
was reduced by 20% of baseline MAP. Bradycardia 
was labeled when the HR of the patient dropped 
below 50 beats/minute. The baseline heart rate (HR) 
and mean arterial pressure (MAP) of all patients were 
recorded before the TAP block. HR and MAP were 
recorded hourly for the first four hours and then five 
hourly for the next 20 hours. Patients were treated 
with a bolus of 5 mg ephedrine intravenously if they 
developed bradycardia and hypotension. 
Data were analyzed using the program, statistical 
package for social sciences (SPSS) version 24. 
Demographic data including name, age, body mass 
index (BMI), and contact were noted on a specially 
designed proforma. Quantitative variables like age 
and BMI and were measured in the form of mean ± SD 
(Standard Deviation). Qualitative data like ASA class 
was expressed as a percentage. Both groups were 
compared by using independent-Sample T test-taking 




The demographic data of both groups were 
comparable. The age range of the patients who 
participated in this study was from 43 years to 60 
years with a mean and standard deviation of 52.64 ± 
4.67 years. The mean and standard deviation in group 
B was 51.80 ± 5.12 years, while it was 53.48±4.11 years 
in group BD with a p-value of 0.207. Out of fifty 
patients, 16 (32%) were ASA I while 34 (68%) were 
ASA II. In group Bout of twenty-five, 10 (40%) patients 
were ASA I while 15 (60%) were ASA II. In group BD 
out of twenty-five, 6 (24%) patients were ASA I while 
19 (76%) were ASA II. P-value was 0.230. The mean 
and standard deviation of BMI in group B was 25.12 ± 
1.66 kg/m2, while for group BD it was 25.64 ± 1.65 
kg/m2 with a p-value of 0.274. A detailed comparison 
is shown in Table 1. 
 
 
Table 1: Comparison of Demographic Data of Both Groups 
Age (Years) Group B Group BD P-value 
Mean ± SD of age (years) 51.80 ± 5.12 53.48 ± 4.11 0.207 
Mean + SD of Body Mass Index (kg/m2) 25.12 ± 1.66 25.64 ± 1.65 0.274 
Frequency (%) of the American Society of 
Anesthesiology (ASA) Status 
ASA I 10 (40%) 6 (24%)  
0.230 
ASA II 15 (60%) 19 (76%) 
 
A significant difference was noted in post-operative analgesia requirements in both groups. Group BD patients 
required their first dose of analgesia significantly later than those of group B. Similarly, the total analgesic 
requirement in group BD patients was significantly less as compared to group B patients. A detailed comparison 
is shown in Table 2. 
 
Table 2: Comparision Of Postoperative Analgesia Requirement in both groups 
Analgesic requirement Group Mean ± Standard Deviation P-value 
Time of 1ST Dose of Analgesia B 302.92 ± 24.01 Minutes 0.001 
BD 419.28 ± 31.97 Minutes 
Nalbuphine consumption in 1st 24 hours B 14.20 ± 2.36 mg 0.001 
BD 10.40 ± 1.38 mg 
 
There was an insignificant difference in hemodynamic parameters in both groups. Hypotension was not seen in 
any patient in either group. Hypotension wasn’t seen in any group, whereas only 1 (4%) patient had bradycardia 
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Discussion 
 
Transversus abdominis plane block was first 
demonstrated by Dr. Rafi AN in the year 2001.11 He 
used the surface landmarks technique to give single-
shot local anesthetics in transversus abdominis plane 
through an angle of Petit. Later in 2007, Hebbard P et 
al. described the TAP block under ultrasound 
guidance.12 
In our study, we observed that adding adjunct 
dexmedetomidine to bupivacaine for TAP block 
provides excellent postoperative analgesia in patients 
who underwent hysterectomy under general 
anesthesia.  It did not only delay the first rescue 
analgesia requirement but also significantly reduced 
the first 24 hours consumption of opioids. A study 
conducted by Almarakbi WA et al. demonstrated 
similar results to that of our study.8 In a similar study 
conducted by Elhamamy N et al13 compared the effects 
of TAP block in four different groups. Group one 
received saline placebo, group two received 
bupivacaine, group three received bupivacaine with 
dexmedetomidine, and group four received 
bupivacaine with dexamethasone. They observed that 
the addition of both dexamethasone and 
dexmedetomidine as an adjunct to local anesthetic in 
TAP block improves the quality and duration of 
analgesia but dexmedetomidine was superior to 
dexamethasone in this regard. 
Various other studies have shown that adding 
dexmedetomidine to local anesthetics can prolong the 
duration and provide better quality analgesia as 
compared to local anesthetics only.14-17 
In our study, no patient developed post-operative 
hypotension from either group but one patient 
developed postoperative bradycardia in group BD. 
Conflicting results were seen in a study conducted by 
Almarakbi WA et al.8 They observed significant 
bradycardia in group BD during the first four 
postoperative hours. 
Contrary to our results, Ding W et al. concluded in 
their study that the addition of dexmedetomidine to 
local anesthetic does not significantly prolong the 
duration or improve the quality of analgesia of TAP 
block.18 
The field of anesthesiology has made huge 
advancements in the last few decades. The 
introduction of regional blocks including TAP block 
and various adjuncts for regional blocks have 
dramatically improved patient satisfaction, allowed 
early ambulation, and shorter hospital stays. TAP 
block brings another addition to the repertoire of 
multimodal analgesia for anesthesiologists for various 
abdominal surgeries. We encourage the use of this 
underutilized modality. However, further research 
and experience for the safe use of this technique and 





It was concluded in our study that the addition of 
dexmedetomidine to bupivacaine for TAP block for 
postoperative analgesia significantly prolongs the 
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